Order Article Reprints

Dorostkar H, Haghiralsadat BF, Hemati M, Safari F, Hassanpour A, Naghib SM, Roozbahani MH, Mozafari MR, Moradi A. Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies. Pharmaceutics. 2023; 15(7):1920. https://doi.org/10.3390/pharmaceutics15071920

Dorostkar, Hamidreza, Bibi Fatemeh Haghiralsadat, Mahdie Hemati, Fatemeh Safari, Azam Hassanpour, Seyed Morteza Naghib, Mohammad Hossein Roozbahani, M. R. Mozafari, and Ali Moradi. 2023. "Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies" Pharmaceutics 15, no. 7: 1920. https://doi.org/10.3390/pharmaceutics15071920

Dorostkar, H., Haghiralsadat, B. F., Hemati, M., Safari, F., Hassanpour, A., Naghib, S. M., Roozbahani, M. H., Mozafari, M. R., & Moradi, A. (2023). Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies. Pharmaceutics, 15(7), 1920. https://doi.org/10.3390/pharmaceutics15071920